Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Wu X, Parekh P, Lin BD, Pries LK, Guloksuz S, Rutten BPF, Andreassen OA, Linden DEJ, van der Meer D(2025) Exploration of Genetic Overlap of Brain Phenotypes With Schizophrenia: Different Methods Provide Complementary Insights Schizophr Bull(in press) DOI 10.1093/schbul/sbaf096, PubMed 40579369
Hurley JH, Coyne AN, Miączyńska M, Stenmark H(2025) The expanding repertoire of ESCRT functions in cell biology and disease Nature(in press) DOI 10.1038/s41586-025-08950-y, PubMed 40562928
Chung BK, Jördens MS, Øgaard J, Reims HM, Flateland B, Luedde T, Jiang X, Karlsen TH, Melum E(2025) Multimodal transcriptomics identifies metallothionein as a novel pathway in primary sclerosing cholangitis Hepatology(in press) DOI 10.1097/HEP.0000000000001432, PubMed 40560681